Abstract:Aqueous solubility is one of the most important physicochemical properties of drug molecules and a major driving force for oral drug absorption. To date, the performance of in silico models for the estimation of solubility for novel chemical space is limited. To investigate possible reasons and remedies for this, the Johnson and Johnson in-house aqueous solubility data with over 40,000 compounds was leveraged. All data were generated through the same high-throughput assay, providing a unique opportunity to explore the relationship between data quality, quantity, and model estimations. Six intrinsic solubility data sets with different sizes and noise levels were generated by making use of three different approaches: (i) inclusion or exclusion of amorphous solid residue, (ii) measured or experimental log D to identify the intrinsic solubility, and (iii) adopting or omitting a quality check process in the data processing workflow. A random forest regressor was trained on the data sets with three different sets of descriptors calculated from RDKit, ADMET predictor, or Mordred, and the performances were evaluated with nested cross-validation as well as ten refined test sets. The models confirm, as expected, that with the same data set size, high-quality data leads to better model performance; however, also, models trained with larger data sets containing analytical variability can give equally accurate estimations compared to models trained with small, clean, and diverse data sets. However, noise introduced by including the presence of amorphous solid postsolubility measurement in the training data set cannot be overcome by increasing data size, as they are introducing a biased systematic positive error in the data set, confirming the importance of critical data review. Finally, two top-performing models were tested on the first test set from the second solubility challenge, achieving RMSE values of 0.74 and 0.72 and log S ± 0.5 of 46 and 48%, respectively. These results demonstrated improved performance compared to those reported in the findings of the competition, highlighting that a single-source curated data set can enhance the prediction of intrinsic solubility.

Solubility-driven lead optimisation: Recent examples and personal perspectives

Innovative medicinal chemistry strategies for enhancing drug solubility

Analysis and optimization of drug solubility to improve pharmacokinetics

Recent advances on aqueous solubility prediction.

Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs

Effect of Data Quality and Data Quantity on the Estimation of Intrinsic Solubility: Analysis Based on a Single-Source Data Set

Recent Patents on Solid Dispersions Emphasize Promising Benefits in Solubility Enhancement of Poorly Water-soluble Drugs

[Lead compound optimization strategy (3)--Structure modification strategies for improving water solubility].

Drug complexes: Perspective from Academic Research and Pharmaceutical Market

Recent advancements toward the incremsent of drug solubility using environmentally-friendly supercritical CO2: a machine learning perspective

Free Energy Perturbation Approach for Accurate Crystalline Aqueous Solubility Predictions

An integrated high-throughput robotic platform and active learning approach for accelerated discovery of optimal electrolyte formulations

Optimizing Nonsink Dissolution Testing for Amorphous Solid Dispersions: Exploring Sample Handling Variables

Solvent Screening for Solubility Enhancement of Theophylline in Neat, Binary and Ternary NADES Solvents: New Measurements and Ensemble Machine Learning

Quantifying solubility enhancement due to particle size reduction and crystal habit modification: case study of acetyl salicylic acid

Improvement in solubility of poor water-soluble drugs by solid dispersion

Multidimensional Protein Solubility Optimization with an Ultrahigh-Throughput Microfluidic Platform

Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs

Mixed Solvency Concept to Replace Harmful Organic Solvent: Recent Trends and Future Challenges in Formulation Development

Insoluble drug delivery strategies: review of recent advances and business prospects

Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics